The promise of quick gains, sharper focus, and boosted energy sounds appealingespecially when paired with no doctor
Retatrutides substantial fat loss over 48 weeks may produce some loose skin in individuals losing 50+ lbs, similar to any approach achieving comparable results
Cagrilintide vs AOD 9604 Mechanism: Cagrilintide: Amylin receptor agonist (appetite/satiety) AOD 9604: HGH fragment (fat metabolism) Completely different Weight loss: Cagrilintide: 10-12% body weight AOD 9604: 5-8% body weight (less robust data) Cagrilintide superior Clinical evidence: Cagrilintide: Extensive Phase 2/3 trials AOD 9604: Limited clinical data Cagrilintide better studied Side effects: Cagrilintide: GI effects common AOD 9604: Minimal side effects AOD 9604 better tolerated Combination potential: Could theoretically combine (different mechanisms) No clinical data on combination Cagrilintide + semaglutide better established Verdict: Cagrilintide more powerful, better evidence
If CagriSema truly prevents the metabolic slowdown associated with weight loss, as the preclinical data suggests, it could produce more durable outcomes with less weight regain after treatment completion
You can remove fat thats weighing on the skin and create a small amount of retraction using either CoolSculpting or Kybella (both of these treatments target the fat but have been shown clinically to cause a small amount of skin tightening or retraction, as well)
Both reasons are valid but the approach, expectations, and oversight should differ accordingly